Biologics Contract Manufacturing Market Segments by Application 2030
Biologics Contract Manufacturing Market Growth & Trends The global biologics contract manufacturing market size is expected to reach USD 34.7 billion by 2030, registering a CAGR of 10.5% over the forecast period, according to a new report by Grand View Research, Inc. The global market was growing efficiently during the COVID-19 pandemic. This is due to a rise in R&D activities for the development of COVID-19 vaccines . In addition, there has been an expansion in manufacturing facilities to control the spread of the disease. For instance, in November 2021, Lonza announced that it has decided to expand its microbial development laboratories in Switzerland to support the company’s upcoming projects. Biologics Contract Manufacturing Market Segmentation Grand View Research has segmented the global biologics contract manufacturing market based on product, indication, and region: Based on the Product Insights, the market is segmented into MABs, Recombinant ...